- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Ubiquitin C-terminal hydrolase L1 (UCHL1) is a cytoplasmic protein that is frequently altered in cancer cells and is widely studied in the context of tumor-associated protein regulation and signaling. The UCHL1 Antibody - Cancer Cell Western Blot Antibody is specifically developed for western blot detection of UCHL1 in cancer cell lysates, enabling analysis of tumor-driven changes in protein expression and stability.
UCHL1 Antibody / Cancer Cell Western Blot Antibody, also referred to as PGP9.5 antibody or ubiquitin C-terminal hydrolase L1 antibody, is optimized for cancer-focused western blot workflows. In tumor cells, UCHL1 expression is often dysregulated and can vary significantly across cancer types, making it a valuable marker for comparative analysis between normal and malignant samples. Western blot detection of UCHL1 provides a direct method for assessing tumor-associated shifts in ubiquitin-mediated protein regulation.
This recombinant mouse monoclonal UCHL1 Antibody (clone rUCHL1/8133) is engineered for consistent performance in western blot assays using cancer-derived protein samples. Its recombinant monoclonal format ensures controlled epitope recognition and reduced non-specific binding, which is critical when analyzing complex tumor lysates that contain heterogeneous protein populations. The antibody supports clear detection of UCHL1 across multiple cancer cell lines, enabling side-by-side comparison of expression patterns.
UCHL1 has been linked to oncogenic signaling pathways, including those regulating cell proliferation, apoptosis, and cellular differentiation. Its expression profile in cancer cells can reflect tumor subtype, progression state, or response to experimental treatments. Western blot analysis using a cancer-focused UCHL1 antibody allows researchers to monitor these biologically relevant changes at the protein level in tumor models and cell-based systems.
A recombinant mouse monoclonal UCHL1 Antibody / Cancer Cell Western Blot Antibody is ideally suited for western blot applications centered on cancer cell biology, tumor lysate analysis, and comparative protein expression across malignancies. Its positioning as a tumor-focused detection tool makes it distinct from general UCHL1 antibodies and highly relevant for oncology research workflows.
Optimal dilution of the UCHL1 Antibody / Cancer Cell Western Blot Antibody should be determined by the researcher.
Recombinant full-length human UCHL1 protein was used as the immunogen for the UCHL1 Antibody / Cancer Cell Western Blot Antibody.
Aliquot the UCHL1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
PGP9.5 antibody, UCHL1 protein antibody, Ubiquitin C-terminal hydrolase L1 antibody, Tumor-associated UCHL1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.